PCM
GRTS

Penserra Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Penserra Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-322
Closed – – 1146
2020
Q3 		$0 Buy
+322
New +$1.2K ﹤0.01% 1055

Other funds holding GRTS

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Penserra Capital Management's GRTS Position: Q4 2020 in Review

Penserra Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2020, closing a stake of 322 shares.

Penserra Capital Management first reported a position in GRTS in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 71 funds tracked by Wall St. Rank hold GRTS as of Q4 2020.

  • Penserra Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Penserra Capital Management sold 322 Gritstone bio, Inc. Common Stock shares in Q4 2020.
  • Penserra Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Penserra Capital Management's Gritstone bio, Inc. Common Stock position peaked at $0 in Q3 2020.
  • 71 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2020.

Based on Penserra Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.